Number of Shares
831.00
Current Holdings Value*
$94,920.00
% of Portfolio
2.94%
Total Estimate Gain
$26,366.27
% of Total Estimate Gain
9.17%

S&P SmallCap 600 Pure Growth Fund's Corcept Therapeutics Inc Holding Summary

As of 2025-03-31, RYDEX SERIES FUNDS held 831.00 shares of Corcept Therapeutics Inc(CORT), totaling $94,920.00. This investment constitutes 2.94% of their stock portfolio, and RYDEX SERIES FUNDS now holds 0% of the outstanding Corcept Therapeutics Inc(CORT) stock.

The initial trade took place in 2019Q3. And since then S&P SmallCap 600 Pure Growth Fund has made 3 purchases of CORT, at an average price of $19.95, for a total of 14,409.00 shares. In addition, there have been 6 sales at an average price of $18.78 for 13,578.00 shares. Based on historical transaction data and CORT's current price of $70.86, S&P SmallCap 600 Pure Growth Fund's estimated gain on his CORT holdings is $26,366.27, reflecting a 9.17% gain to date.

S&P SmallCap 600 Pure Growth Fund CORT ($70.86) Holding Chart

S&P SmallCap 600 Pure Growth Fund CORT ($70.86) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1